Los Angeles Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 61,759 shares of IOVA stock, worth $346,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,759
Previous 61,759
-0.0%
Holding current value
$346,467
Previous $579,000
21.07%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IOVA
# of Institutions
340Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$154 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$137 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$124 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$119 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$68.7 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $885M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...